984 related articles for article (PubMed ID: 18449062)
41. The association of respiratory syncytial virus infection and influenza with emergency admissions for respiratory disease in London: an analysis of routine surveillance data.
Mangtani P; Hajat S; Kovats S; Wilkinson P; Armstrong B
Clin Infect Dis; 2006 Mar; 42(5):640-6. PubMed ID: 16447109
[TBL] [Abstract][Full Text] [Related]
42. Palivizumab prophylaxis and hospitalization for respiratory syncytial virus disease in the Stockholm infant population, 1999 through 2002.
Henckel E; Luthander J; Berggren E; Kapadia H; Naver L; Norman M; Bennet R; Eriksson M
Pediatr Infect Dis J; 2004 Jan; 23(1):27-31. PubMed ID: 14743042
[TBL] [Abstract][Full Text] [Related]
43. The epidemiology of respiratory syncytial virus lower respiratory tract infections in children less than 5 years of age in Indonesia.
Simões EA; Mutyara K; Soh S; Agustian D; Hibberd ML; Kartasasmita CB
Pediatr Infect Dis J; 2011 Sep; 30(9):778-84. PubMed ID: 21487330
[TBL] [Abstract][Full Text] [Related]
44. Respiratory syncytial virus--United States, July 2007-June 2011.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Sep; 60(35):1203-6. PubMed ID: 21900874
[TBL] [Abstract][Full Text] [Related]
45. Respiratory syncytial virus activity--United States, 1999-2000 season.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2000 Dec; 49(48):1091-3. PubMed ID: 11130859
[TBL] [Abstract][Full Text] [Related]
46. Respiratory syncytial virus-related bronchiolitis in Puerto Rico.
Molinari Such M; García I; García L; Puig G; Pedraza L; Marín J; Valcárcel M
P R Health Sci J; 2005 Jun; 24(2):137-40. PubMed ID: 16116931
[TBL] [Abstract][Full Text] [Related]
47. Beyond randomized controlled trials: a "real life" experience of respiratory syncytial virus infection prevention in infancy with and without palivizumab.
Mitchell I; Tough S; Gillis L; Majaesic C
Pediatr Pulmonol; 2006 Dec; 41(12):1167-74. PubMed ID: 17058279
[TBL] [Abstract][Full Text] [Related]
48. Respiratory syncytial virus infection and immunoprophylaxis for selected high-risk children in Central Australia.
Bolisetty S; Wheaton G; Chang AB
Aust J Rural Health; 2005 Oct; 13(5):265-70. PubMed ID: 16171499
[TBL] [Abstract][Full Text] [Related]
49. Predictive value of the respiratory syncytial virus risk-scoring tool in the term infant in Canada.
Paes B; Cole M; Latchman A; Pinelli J
Curr Med Res Opin; 2009 Sep; 25(9):2191-6. PubMed ID: 19604126
[TBL] [Abstract][Full Text] [Related]
50. RSV frequency in children below 2 years hospitalized for lower respiratory tract infections.
Hacımustafaoğlu M; Celebi S; Bozdemir SE; Ozgür T; Ozcan I; Güray A; Cakır D
Turk J Pediatr; 2013; 55(2):130-9. PubMed ID: 24192672
[TBL] [Abstract][Full Text] [Related]
51. Respiratory syncytial virus infection among hospitalized young children with acute lower respiratory illnesses in Al Ain, UAE.
Uduman SA; Ijaz MK; Kochiyil J; Mathew T; Hossam MK
J Commun Dis; 1996 Dec; 28(4):245-52. PubMed ID: 9057448
[TBL] [Abstract][Full Text] [Related]
52. Brief report: respiratory syncytial virus activity--United States, July 2006-November 2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Dec; 56(48):1263-5. PubMed ID: 18059258
[TBL] [Abstract][Full Text] [Related]
53. A novel active respiratory syncytial virus surveillance system in the United States: variability in the local and regional incidence of infection.
Boron ML; Edelman L; Groothuis JR; Malinoski FJ
Pediatr Infect Dis J; 2008 Dec; 27(12):1095-8. PubMed ID: 18989237
[TBL] [Abstract][Full Text] [Related]
54. Excretion patterns of human metapneumovirus and respiratory syncytial virus among young children.
von Linstow ML; Eugen-Olsen J; Koch A; Winther TN; Westh H; Hogh B
Eur J Med Res; 2006 Aug; 11(8):329-35. PubMed ID: 17052968
[TBL] [Abstract][Full Text] [Related]
55. Hospitalizations for acute lower respiratory tract infection due to respiratory syncytial virus in Thailand, 2008-2011.
Naorat S; Chittaganpitch M; Thamthitiwat S; Henchaichon S; Sawatwong P; Srisaengchai P; Lu Y; Chuananon S; Amornintapichet T; Chantra S; Erdman DD; Maloney SA; Akarasewi P; Baggett HC
J Infect Dis; 2013 Dec; 208 Suppl 3():S238-45. PubMed ID: 24265483
[TBL] [Abstract][Full Text] [Related]
56. Hospital admission of high risk infants for respiratory syncytial virus infection: implications for palivizumab prophylaxis.
Heikkinen T; Valkonen H; Lehtonen L; Vainionpää R; Ruuskanen O
Arch Dis Child Fetal Neonatal Ed; 2005 Jan; 90(1):F64-8. PubMed ID: 15613580
[TBL] [Abstract][Full Text] [Related]
57. Long-term consequences of respiratory syncytial virus acute lower respiratory tract infection in early childhood in Guinea-bissau.
Poulsen A; Stensballe LG; Nielsen J; Benn CS; Balde A; Roth A; Lisse IM; Aaby P
Pediatr Infect Dis J; 2006 Nov; 25(11):1025-31. PubMed ID: 17072125
[TBL] [Abstract][Full Text] [Related]
58. Appropriateness of age thresholds for respiratory syncytial virus immunoprophylaxis in moderate-preterm infants: a cohort study.
Winterstein AG; Knox CA; Kubilis P; Hampp C
JAMA Pediatr; 2013 Dec; 167(12):1118-24. PubMed ID: 24126903
[TBL] [Abstract][Full Text] [Related]
59. Occurrence of respiratory syncytial virus subtypes in Mexican infants with acute lower respiratory tract disease.
Tirado R; Sarmiento RE; Bustos J; Thompson O; Gomez B
Arch Med Res; 1995; 26(2):121-6. PubMed ID: 7620276
[TBL] [Abstract][Full Text] [Related]
60. Epidemiology of respiratory syncytial virus infection in northern Taiwan, 2001-2005 -- seasonality, clinical characteristics, and disease burden.
Lee JT; Chang LY; Wang LC; Kao CL; Shao PL; Lu CY; Lee PI; Chen JM; Lee CY; Huang LM
J Microbiol Immunol Infect; 2007 Aug; 40(4):293-301. PubMed ID: 17712463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
